
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny is a rapidly growing fertility benefits company with a strong focus on compliance and a unique product, ProgynyRx, which sets them apart in the market. Despite competition and potential challenges, the company remains disciplined and optimistic in its growth potential, making it an attractive investment opportunity for analysts.
Bears say
Progyny is facing headwinds due to slowing growth in the 50K+ client category and potential divestments. Furthermore, there are concerns over potential competition from health plans and regulatory risk. Their seasonal revenue patterns may also lead to volatility in earnings. However, Progyny's focus on healthcare integration, specialization in the growing fertility market, and long-term strong financial performance suggest potential for future growth and profitability.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares